title: Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol.
abstract: The effects of tolerance to l-trans-delta 9-tetrahydrocannabinol (THC) following repeated administration and of subsequent abstinence following drug withdrawal on the cellular immune function were determined in female B6C3F1 mice. Mice were injected with THC (10 mg/kg s.c.) twice daily for 4 days. On day 5, analgesic response to various doses of THC was determined using the tail flick test. Similarly, hypothermic response to THC was also determined. Multiple injections of THC resulted in the development of tolerance to both the analgesic and hypothermic effects of THC. Immune function studies were performed on mice rendered tolerant to or abstinent from THC by these procedures. Neither tolerance nor abstinence subsequent to a 4-day THC administration had any effect on either body weight or thymus weight and cellularity, although both spleen weight and cellularity were decreased in THC-abstinent animals. Likewise, no significant effects on B cell proliferation were observed in either tolerant or abstinent mice. The production of the cytokine interleukin-2 by T helper cells was markedly suppressed in both tolerant and abstinent mice, whereas the production of interleukin-4 was significantly suppressed only in THC-abstinent mice. Significant suppression of tumor cell cytolysis mediated by cytotoxic T cells and natural killer cells was only observed in THC-abstinent mice. These results suggest that THC-mediated modulation of the immune response may result from a differential effect on cellular populations.
authors.affiliation: Department of Pharmaceutics and Pharmacodynamics, University of Illinois at Chicago 60612, USA.
authors.forename: H N
authors.initials: HN
authors.lastname: Bhargava
authors.forename: R V
authors.initials: RV
authors.lastname: House
authors.forename: S N
authors.initials: SN
authors.lastname: Thorat
authors.forename: P T
authors.initials: PT
authors.lastname: Thomas
mesh_terms: D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002455:Cell Division; D016207:Cytokines / Q000096:biosynthesis; D013759:Dronabinol / Q000009:adverse effects / Q000494:pharmacology*; D004361:Drug Tolerance; D005260:Female; D007111:Immunity, Cellular / Q000187:drug effects*; D007694:Killer Cells, Natural / Q000187:drug effects; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009929:Organ Size / Q000187:drug effects; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000494:pharmacology*; D013154:Spleen / Q000166:cytology; D013375:Substance Withdrawal Syndrome / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects
chemical_list: D000700:Analgesics; D016207:Cytokines; D011619:Psychotropic Drugs; D013759:Dronabinol